
Hadean Ventures
Description
Hadean Ventures is a specialized life science fund manager based in Oslo, Norway, with a strategic focus on investing in innovative life science companies across Europe, particularly emphasizing the Nordic region. The firm manages funds with total commitments exceeding EUR 200 million, equivalent to over $216 million, underscoring its significant capital base dedicated to the sector. Their investment mandate covers a broad spectrum of life science innovations, including pharmaceuticals, medical devices, diagnostics, and digital health technologies, aiming to support the development of groundbreaking solutions that address critical healthcare needs.
The firm primarily targets companies raising their Series A or Series B funding rounds, indicating a preference for early to growth-stage ventures that have demonstrated initial traction or proof-of-concept. Hadean Ventures typically deploys initial investments ranging from EUR 3 million to EUR 10 million, which translates to approximately $3.24 million to $10.8 million. This range positions them as a key financial partner for companies seeking substantial capital to advance their research, development, and commercialization efforts. They also have the capacity to invest up to EUR 20 million over the lifetime of a portfolio company, demonstrating a commitment to long-term support.
Hadean Ventures distinguishes itself through its team's deep scientific and commercial expertise, which enables them to provide more than just capital. They actively engage with their portfolio companies, offering strategic guidance, operational support, and access to their extensive network within the life science industry. This hands-on approach is designed to accelerate the growth and success of their investments, fostering the development of companies that can make a significant impact on global health. Their strategic location in Norway further strengthens their access to the vibrant Nordic life science ecosystem, a region known for its strong research institutions and innovative startups.
Investor Profile
Hadean Ventures has backed more than 25 startups, with 1 new investments in the last 12 months alone. The firm has led 11 rounds, about 44% of its total and boasts 5 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series Unknown, Series B rounds (top funding stages).
- Majority of deals are located in Sweden, Norway, Germany.
- Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
- Typical check size: $3.2M – $10.8M.
Stage Focus
- Series A (36%)
- Series Unknown (24%)
- Series B (20%)
- Series D (8%)
- Series C (8%)
- Post Ipo Equity (4%)
Country Focus
- Sweden (32%)
- Norway (16%)
- Germany (12%)
- Austria (8%)
- United States (8%)
- Denmark (4%)
- The Netherlands (4%)
- Finland (4%)
- Spain (4%)
- United Kingdom (4%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Medical
- Biopharma
- Therapeutics
- Artificial Intelligence (Ai)
- Software
- Clinical Trials
- Genetics
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.